Earnings History Data for Kinnate Biopharma Inc. (KNTE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kinnate Biopharma Inc.

Kinnate Biopharma Inc. is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Kinnate Biopharma Inc. is based in SAN FRANCISCO, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-08-2023	AH		KNTE	Kinnate Biopharma	135.00	-0.68	-0.76	0.00	Kinnate Biopharma GAAP EPS of -$0.68 beats by $0.08 [8/8/2023 5:57 PM]	2.68	0.04 (1.52%)	2.64	0.0 (0.00%)	2.32 - 15.86	131,617	180,000	223
Kinnate Biopharma GAAP EPS of -$0.68 beats by $0.08 [8/8/2023 5:57 PM]
15-03-2023	AH	4:05 PM ET (Mar 15)	KNTE	Kinnate Biopharma	191.00	-0.72	-0.70	0.00	Kinnate Biopharma GAAP EPS of -$2.64 in-line [3/15/2023 5:08 PM]	5.49	0.82 (17.56%)	4.67	0.0 (0.00%)	3.30 - 15.86	145,875	120,000	6,492
Kinnate Biopharma GAAP EPS of -$2.64 in-line [3/15/2023 5:08 PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	KNTE	Kinnate Biopharma	651.00	-0.62	-0.65	0.00	Kinnate Biopharma GAAP EPS of -$0.62 beats by $0.03 [8/11/2022 5:53 PM]	15.84	2.51 (18.83%)	13.33	0.0 (0.00%)	7.17 - 26.05	366,406	140,000	1,439
Kinnate Biopharma GAAP EPS of -$0.62 beats by $0.03 [8/11/2022 5:53 PM] Kinnate Biopharma Inc. Announces Second Quarter 2022 Financial Results and Recent Corporate Updates [Aug-11-22 04:05PM]
12-05-2022	AH	4:05 PM ET (May 12)	KNTE	Kinnate Biopharma	369.00	-0.61	-0.62	0.00	Kinnate Biopharma GAAP EPS of -$0.61 [5/12/2022 4:59 PM]	9.34	0.71 (8.23%)	8.63	0.0 (0.00%)	7.29 - 27.00	61,833	150,000	4,956
Kinnate Biopharma GAAP EPS of -$0.61 [5/12/2022 4:59 PM] Kinnate Biopharma Inc. Reports First Quarter 2022 Financial Results and Provides Operational Updates [May-12-22 04:05PM]
28-03-2022	AH		KNTE	Kinnate Biopharma	481.00	-0.60	-0.60	0.00	Kinnate Biopharma GAAP EPS of -$2.06 misses by $0.01 [3/28/2022 4:41 PM]	13.04	2.67 (25.75%)	10.37	0.0 (0.00%)	7.42 - 32.79	200,215	170,000	1,303
Kinnate Biopharma GAAP EPS of -$2.06 misses by $0.01 [3/28/2022 4:41 PM] Kinnate Biopharma Inc. Reports Full Year 2021 Financial Results and Provides Operational Updates [Mar-28-22 04:05PM]
10-11-2021	AH		KNTE	Kinnate Biopharma	1,074	-0.57	-0.55	0.00	Kinnate Biopharma EPS misses by $0.04 [11/10/2021 5:05 PM]	23.30	-0.31 (-1.31%)	23.61	0.0 (0.00%)	17.58 - 48.75	67,891	60,000	1,326
Kinnate Biopharma EPS misses by $0.04 [11/10/2021 5:05 PM] Kinnate Biopharma Inc. Reports Third Quarter 2021 Financial Results [Nov-10-21 04:05PM]
17-05-2021	AH		KNTE	Kinnate Biopharma Inc.	965.00	-0.40	-0.37	0.00	Kinnate Biopharma EPS misses by $0.01 [5/17/2021 4:43 PM]	25.85	2.60 (11.18%)	23.25	0.0 (0.00%)	21.27 - 48.75	123,548	160,000	3,029
Kinnate Biopharma EPS misses by $0.01 [5/17/2021 4:43 PM] Kinnate Biopharma up 13% as lead program gets IND clearance, phase 1 start date [5/18/2021 3:27 PM] Kinnate Biopharma Inc. Reports First Quarter 2021 Financial Results and Announces FDA Clearance of Investigational New Drug Application for KIN-2787 [May-17-21 04:05PM]